Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Benazir Saleem"'
Autor:
Lorraine Green, Ariane L Herrick, Michelle Wilson, Francesco Del Galdo, Enrico De Lorenzis, Philip Helliwell, Benazir Saleem, Emma Derrett-Smith, Begonya Alcacer-Pitarch, Karen Douglas, Vishal Kakkar, Chris Denton, Theresa Barnes, Stefano Di Donato, Muhammad Nisar, Catherine Morley
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Background Hand involvement is an early manifestation of systemic sclerosis (SSc), culprit of diagnosis and classification, and recognised major driver of disability. Impairment of hand function burdens both limited and diffuse cutaneous subsets and
Externí odkaz:
https://doaj.org/article/7b56cfd98b3d45acba6ab68e802e796f
Autor:
Kulveer Mankia, Paul Emery, Lesley-Anne Bissell, Brendan Clarke, Darren Newton, Rebecca L Ross, Laurence Duquenne, Benazir Saleem, Aamir Aslam, Pam Hughes, Diane Corsadden, Clive Carter, Fatima A Nadat, Panji Mulipa, Mark Lobb, Katie Mbara, Ruth Morton, Sophie Dibb, Rahaymin Chowdhury, Alexandra Pike, Vishal Kakkar, Sinisia Savic, Francesco DelGaldo
Publikováno v:
RMD Open, Vol 8, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/5dde514756a244ce8e1b853f8feac6a2
Autor:
Md Yuzaiful Md Yusof, Jack Arnold, Benazir Saleem, Claire Vandevelde, Shouvik Dass, Sinisa Savic, Edward M Vital, Paul Emery
Publikováno v:
The Lancet Rheumatology. 5:e88-e98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ddfcb6538ec13c9ac0640cb63654841
https://doi.org/10.1016/s2665-9913(23)00004-8
https://doi.org/10.1016/s2665-9913(23)00004-8
Autor:
Joanna McLorinan, Maria Slade, Chi-han Leong, Josie Baker, Lynda Bailey, Jacqueline Nam, Lesley-Anne Bissell, Paul Emery, Shouvik Dass, Benazir Saleem
Publikováno v:
Rheumatology. 62
Background/Aims When the COVID-19 pandemic began, steps were taken to minimise risk to those vulnerable to severe outcomes. For immunosuppressed patients with rheumatoid arthritis (RA), consideration was given to reducing risk whilst mindful of compr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::465c6b1f10095e689e52b4dff9917e17
https://doi.org/10.1093/rheumatology/kead104.180
https://doi.org/10.1093/rheumatology/kead104.180
Autor:
Benazir Saleem, Rebecca L Ross, Lesley-Anne Bissell, Aamir Aslam, Kulveer Mankia, Laurence Duquenne, Diane Corsadden, Clive Carter, Pam Hughes, Fatima A Nadat, Panji Mulipa, Mark Lobb, Brendan Clarke, Katie Mbara, Ruth Morton, Sophie Dibb, Rahaymin Chowdhury, Darren Newton, Alexandra Pike, Vishal Kakkar, Sinisia Savic, Francesco DelGaldo, Paul Emery
ObjectivesTo assess antibody and T cell responses to SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on disease-modifying antirheumatic drugs (DMARDs).MethodsThis prospective study recruited 100 patients with RA on a variety of DMAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a85ddb47a7cd090612e6d5031adb8bdc
https://eprints.whiterose.ac.uk/186610/1/e002050.full.pdf
https://eprints.whiterose.ac.uk/186610/1/e002050.full.pdf
Publikováno v:
Healthcare
Healthcare, Vol 9, Iss 1726, p 1726 (2021)
Healthcare, Vol 9, Iss 1726, p 1726 (2021)
Background: It is now accepted that the optimum treatment goal for rheumatoid arthritis (RA) is sustained remission, as this has been shown to be associated with the best patient outcomes. There is little guidance on how to manage patients once remis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be0975cd5c60963c3b42de1be0b81061
https://pubmed.ncbi.nlm.nih.gov/34946453
https://pubmed.ncbi.nlm.nih.gov/34946453
Publikováno v:
The Lancet. Rheumatology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0d9bd44dec8ab439ab1e58681b464f3
https://doi.org/10.1016/s2665-9913(22)00027-3
https://doi.org/10.1016/s2665-9913(22)00027-3
Autor:
Benazir Saleem, Lynda Bailey, Shouvik Dass, Paul Emery, Andrew Melville, L. Garcia-Montoya, Maya H Buch, Yuzaiful Md Yusof, John Fitton
Publikováno v:
Rheumatology.
Objective To evaluate the impact of non-medical switch from rituximab originator (RTX-O) to biosimilar (RTX-B) in patients with RA. Methods Between October 2017 and October 2019, all patients on RTX-O in our centre requiring re-treatment were switche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e750a1d3bf5db071a3d406e66c98c1fd
https://doi.org/10.1093/rheumatology/keaa834
https://doi.org/10.1093/rheumatology/keaa834
Autor:
Andrew R, Melville, Md Yuzaiful, Md Yusof, John, Fitton, Leticia, Garcia-Montoya, Lynda, Bailey, Shouvik, Dass, Paul, Emery, Maya H, Buch, Benazir, Saleem
Publikováno v:
Rheumatology (Oxford, England). 60(8)
To evaluate the impact of non-medical switch from rituximab originator (RTX-O) to biosimilar (RTX-B) in patients with RA.Between October 2017 and October 2019, all patients on RTX-O in our centre requiring re-treatment were switched to RTX-B unless d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e6e034f20da4a3f810493af7179ce68
https://pubmed.ncbi.nlm.nih.gov/33432358
https://pubmed.ncbi.nlm.nih.gov/33432358
Autor:
Benazir Saleem, Dennis McGonagle, Charlie Bridgewood, Miriam Wittmann, Abhay Rao, Kassem Sharif, Tobias Russell, Peter Loughenbury, Almas Khan, Abdulla Watad, Jane E. Freeston
Publikováno v:
Rheumatology (Oxford, England). 60(5)
Objectives Dupilumab blocks the IL-4 receptor (IL-4R) and thus signalling of the ‘Th2’ cytokines IL-4 and IL-13. It has a license to treat atopic eczema and was recently linked to emergent enthesitis and psoriasis. We investigated the cellular an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b710c942e20d571c065bb216f0366adf
https://pubmed.ncbi.nlm.nih.gov/33253386
https://pubmed.ncbi.nlm.nih.gov/33253386